| New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies H Elkady, A Elwan, HA El-Mahdy, AS Doghish, A Ismail, MS Taghour, ... Journal of enzyme inhibition and medicinal chemistry 37 (1), 403-416, 2022 | 102 | 2022 |
| New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis NA Alsaif, MA Dahab, MM Alanazi, AJ Obaidullah, AA Al-Mehizia, ... Bioorganic Chemistry 110, 104807, 2021 | 74 | 2021 |
| New bis ([1, 2, 4] triazolo)[4, 3-a: 3′, 4′-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer … MM Alanazi, HA Mahdy, NA Alsaif, AJ Obaidullah, HM Alkahtani, ... Bioorganic Chemistry 112, 104949, 2021 | 65 | 2021 |
| Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease AA Al-Karmalawy, R Alnajjar, M Dahab, A Metwaly, I Eissa Pharmaceutical Sciences 27 (Covid-19), S109-S121, 2021 | 61 | 2021 |
| New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah, HM Alkahtani, ... RSC advances 11 (48), 30315-30328, 2021 | 52 | 2021 |
| Design and discovery of new antiproliferative 1, 2, 4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site IH Eissa, MA Dahab, MK Ibrahim, NA Alsaif, AZ Alanazi, SI Eissa, ... Bioorganic Chemistry 112, 104965, 2021 | 49 | 2021 |
| Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah, WA Alanazi, ... Journal of Molecular Structure 1253, 132220, 2022 | 38 | 2022 |
| New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies EB Elkaeed, MS Taghour, HA Mahdy, WM Eldehna, NM El-Deeb, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2191-2205, 2022 | 35 | 2022 |
| Modified benzoxazole-based VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, and anti-proliferative evaluation A Elwan, AE Abdallah, HA Mahdy, MA Dahab, MS Taghour, EB Elkaeed, ... Molecules 27 (15), 5047, 2022 | 28 | 2022 |
| Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation MS Taghour, HA Mahdy, MH Gomaa, A Aglan, MG Eldeib, A Elwan, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2063-2077, 2022 | 26 | 2022 |
| Identification of new [1, 2, 4] triazolo [4, 3-a] quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies NA Alsaif, MS Taghour, MM Alanazi, AJ Obaidullah, WA Alanazi, ... Bioorganic & Medicinal Chemistry 46, 116384, 2021 | 22 | 2021 |
| Hordatines as a potential inhibitor of COVID-19 main protease and RNA polymerase: an in-silico approach MA Dahab, MM Hegazy, HS Abbass Natural products and bioprospecting 10, 453-462, 2020 | 19 | 2020 |
| Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting hACE2 receptor I Eissa, A Al-Karmalawy, MA Dahab, AM Metwaly, SS Elhady, EB Elkaeed, ... Front. Chem 9, 227, 2021 | 11 | 2021 |
| Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti … IH Eissa, R El-Haggar, MA Dahab, MF Ahmed, HA Mahdy, RI Alsantali, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1587-1599, 2022 | 10 | 2022 |
| Thieme Chemistry Journals Awardees–Where Are They Now? A Cascade Synthesis of 1, 2, 4-Triazin-3 (2H)-ones Using Nitrogen-Substituted Isocyanates MA Dahab, JS Derasp, AM Beauchemin Synlett 28 (04), 456-460, 2017 | 8 | 2017 |
| New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations HA Mahdy, H Elkady, MS Taghour, A Elwan, MA Dahab, MA Elkady, ... Future Medicinal Chemistry 15 (14), 1233-1250, 2023 | 7 | 2023 |
| Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations MA Dahab, HA Mahdy, H Elkady, MS Taghour, A Elwan, MA Elkady, ... Journal of Biomolecular Structure and Dynamics, 1-20, 2023 | 6 | 2023 |
| Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2, 4-dione derivatives as potential antitumor VEGFR-2 inhibitors H Elkady, OA El-Dardir, A Elwan, MS Taghour, HA Mahdy, MA Dahab, ... RSC advances 13 (40), 27801-27827, 2023 | 6 | 2023 |
| Computer aided drug discovery (CADD) of a thieno[2,3-d]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket EA Sobh, MA Dahab, EB Elkaeed, AA Alsfouk, IM Ibrahim, AM Metwaly, ... Journal of Biomolecular Structure and Dynamics 42 (5), 2369-2391, 2024 | 5 | 2024 |
| Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors EA Sobh, MA Dahab, EB Elkaeed, AA Alsfouk, IM Ibrahim, AM Metwaly, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2220579, 2023 | 5 | 2023 |
Ibrahim H. EissaProfessor, Faculty of pharmacy, Al-Azhar UniversityVerified email at azhar.edu.eg
